With cardiovascular disease being one of the leading causes of death in the United Kingdom and the current healthcare system being under immense pressure, the NHS rolled out a long term plan to tackle this issue. In this plan, cardiovascular…
FibriCheck continuously strives to investigate the role of PPG monitoring in the AF diagnosis pathway. In light of this, we were happy to see that Britt Wouters wanted to conduct a pilot study on this topic during her internship at…
The Staffordshire and Stoke on Trent Integrated Care System (ICS) - has introduced the use of FibriCheck, enabling patients with palpitations to check their heart rhythm from the comfort of home, without need for a hospital visit or additional equipment.
FibriCheck is thrilled to announce its strategic partnership with Pfizer and AlTibbi, the leading digital health platform in the MENA region, by launching the first of its kind awareness campaign to detect atrial fibrillation in the United Arab Emirates (UAE).
With the backing of the CW Innovation initiative, led by Chelsea and Westminster Hospital NHS Foundation Trust and its charity CW+, the West London NHS trust adopted FibriCheck to empower patients to self-monitor signs of atrial fibrillation (AF) from the…
On the occasion of Heart Rhythm Week, the Belgian Heart Rhythm Association (BeHRA) in association with FibriCheck is organising a nationwide campaign to raise awareness of remote heart rhythm monitoring for 10,000 people who are at risk.
Atrial Fibrillation (AF) is one of the leading causes of stroke and often goes undiagnosed due to lack of symptoms.1 It is estimated that 300,000 people are living with undiagnosed AF and that over 2,000 lives could be saved every…
As TeleCheck AF continues to gain traction across the continent, notable strides are being made in the UK, where recently published guidelines cite FibriCheck’s remote heart rhythm monitoring as an example of clinical best practice in the delivery of care for cardiovascular disease…